Founders Capital Management (Texas)’s Boston Scientific BSX Stock Holding History

Founders Capital Management (Texas)’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-300	Closed	-$32.2K	–	397
2025 Q2	$32.2K	Hold	300	–	–	0.02%	181
2025 Q1	$30.3K	Hold	300	–	–	0.02%	177
2024 Q4	$26.8K	Hold	300	–	–	0.02%	194
2024 Q3	$25.1K	Hold	300	–	–	0.02%	208
2024 Q2	$23.1K	Buy	+300	New	+$22K	0.02%	216

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Founders Capital Management (Texas)'s BSX Position: Q3 2025 in Review

Founders Capital Management (Texas) sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 300 shares — an estimated $32.2K sold.

Founders Capital Management (Texas) first reported a position in BSX in Q2 2024 and held it in 5 quarters. The position peaked at $32.2K in Q2 2025. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

Founders Capital Management (Texas) reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
Founders Capital Management (Texas) sold 300 Boston Scientific shares in Q3 2025, an estimated $32.2K.
Founders Capital Management (Texas) first reported a position in Boston Scientific in Q2 2024 and held it in 5 quarters.
Founders Capital Management (Texas)'s Boston Scientific position peaked at $32.2K in Q2 2025.
1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Founders Capital Management (Texas)'s 13F filing for Q3 2025, filed 13 Nov 2025.